Yunnan Hong founder 84 years old to start a business again to obtain financing, inventory pharmaceutical industry "Chu Shijian" people!

They used to be the most famous reform adventurers in the pharmaceutical industry They reached the top of their lives because they created a company, but some of them had no choice but to sell the company; some of them retired from creating a state-owned enterprise; some of them were jailed; some of them collapsed But they don't agree with the old, they still have ambitions in the rare age, and they want to make a name again! On April 18, at the forum of "entrepreneurship ecology and entrepreneur gene in China today" held in Shanghai, an entrepreneur who is an old man appeared at the conference and shared his entrepreneurial story The 84 year old entrepreneur, Zhou Jiageng, was the first chief engineer of Yunnan Baiyao In 1993, he was 60 years old It was the choice of most people to retire and live a stable life, but he chose another way - entrepreneurship At that time, he and 11 other people launched a joint fund raising of 280000 yuan to establish Dianhong pharmaceutical industry Under the leadership of Zhou Jiageng, Dianhong pharmaceutical industry has made great strides, independently developed and produced 11 varieties of Kangwang brand external medicine and other internal medicine Four years later, 280000 became 40 million Twenty years later, the brand of Dianhong Kangwang is well-known, and its sales volume has reached 1.3 billion yuan If we judge the start-up of Zhou Jiaren in turn, he is undoubtedly a success However, since the entrepreneurs of Dianhong pharmaceutical are all over 75 years old, their working energy is declining year by year, and they intend to sell their shares Due to the decentralization of the company's control, Zhou Jiahuan could only accept the sale plan Bayer Group eventually invested 3.6 billion yuan to acquire 100% shares of Dianhong pharmaceutical At that time, Zhou Jiahui was 81 years old, and everyone would think that he would live up to his old age, while Bayer, Germany, would take Dian Hong to a new height and become a Chinese enterprise going to the world However, all the outside speculation is wrong Dian Hong did not get rapid development because of marrying into a powerful family, but because the acquirer and the enterprise did not run well In only two years, the sales scale of Dian Hong pharmaceutical industry dropped rapidly from 1 billion to half of the original; Zhou Jiaren did not live a life of children and grandchildren around the knee, but chose to start a new business three years later In March 2016, Zhou Jiageng and several partners jointly established Yunnan qunyou Biotechnology Co., Ltd., which is engaged in the production and sales of health products and daily chemicals The new company group has absorbed the core team of the original Dianhong, and arranged a more stable company structure: more concentrated equity, cross generation alternative design, long-term team shareholding plan Zhou Jiaren has repeatedly said that if his third venture is successful, he will share his equity with the team, but this time he will not transfer control A year later, qunyou biology, founded by Zhou Jiageng, received round a investment from Shanghai pioneer investment management company Wang Zhuo, founding partner of pioneer capital, became general manager of Shanghai Jiahua He chose to invest in qunyou biology mainly because qunyou has strong research and development ability, clinical experience and historical formula accumulation in the field of plant pharmacy According to reports, at present, three health care products of qunyou biotechnology are being declared to the State Food and drug administration At the same time, daily chemicals with more than 80 bar codes covering all kinds of cosmetics are also being reported Since March this year, qunyou has reorganized large circulation daily chemical products, among which the shampoo with the largest sales volume is the main body, registered new trademark, manufactured and produced small batch of samples After passing the inspection, qunyou will report to Yunnan food and Drug Administration for filing, and put into mass production at the latest in mid June At present, the company has set up R & D center and production base in Yunnan, central marketing department and e-commerce operation center in Shanghai and Hangzhou 1 Zhao Xinxian, founder of Sanjiu Pharmaceutical Co., Ltd.: when Zhao Xinxian was 75 years old and then innovated, people in the pharmaceutical industry should have no idea This legend, who is closely connected with "Sanjiu Weitai" and "Sanjiu group", is bound to attract more attention when he starts his business after he is too old In 1985, Zhao Xinxian went south to Shenzhen for the first time with scientific research achievements such as "Sanjiu Weitai" and a loan of 5 million yuan, and built China's first automatic production line of traditional Chinese medicine on the Bijia mountain with thatched grass Since then, the Sanjiu group, which he founded, has developed into a total asset of more than 20 billion yuan through a series of crazy mergers and acquisitions in the past 20 years It has set foot in eight major industries, namely, medicine, automobile, food, wine making, tourist hotel, commerce, agriculture and real estate Haier and Lenovo, which were born in the first era, can only catch up with each other Zhao Xinxian, who is known as "the father of the modernization of traditional Chinese medicine", won numerous honors at one time, and has no different scenery Sadly, on November 19, 2005, Zhao Xinxian was suddenly arrested and put in the Meilin detention center in Shenzhen, which is only one kilometer away from Bijiashan, the place where he started his business Until 2007, the "Sanjiu Godfather" was sentenced to one year and ten months in prison for "abuse of power" of state-owned company personnel, which disappeared from public view In 2008, Zhao Xinxian was appointed as a consultant by the chairman of Nanjing Xiaoying pharmaceutical company The chairman promised to invest 300 million yuan to build a health platform for traditional Chinese medicine But two months later, the chairman suddenly changed his mind to invest in mining This time, Zhao Xinxian also failed In 2013, Zhao Xinxian was hired as a consultant by a pharmaceutical company in Tianjin During this period, the wife began to take Ganoderma lucidum due to poor sleep, and her insomnia was cured after a period of time This also inspired Zhao Xinxian to study Ganoderma again After going through all the ancient Pharmacopoeia related to ganoderma and investigating the current market of ganoderma, he found that the Ganoderma on the market is basically health products rather than drugs, and Ganoderma has not formed an industrial scale, not to mention a large brand At the beginning of 2014, when Zhao Xinxian contacted Changzhou Weilong pharmaceutical factory again, he found that the factory had been in a dilemma Therefore, Zhao Xinxian found a venture capital institution to jointly purchase Changzhou Weilong pharmaceutical factory After the acquisition, Zhao Xinxian became the largest shareholder After that, the 75 year old legend returned as the "founder of new pioneer pharmaceutical" and started a second venture at the foot of Bijia mountain in Shenzhen From 2014, Ganoderma lucidum was tried to be planted, to 2015, it was planted on a large scale Now, there are three products of Xinxian Ganoderma syrup, Xinxian broken wall ganoderma spore powder capsule and Ganoderma lucidum (original Ganoderma lucidum slice of Changbai Mountain) listed in about 8000 chain drugstores nationwide 2 Xu Xiaoxian, founder of Lizhu group: at the age of 66, he had a family misfortune in his third venture At the age of 13, due to his father's early death, as the eldest son, he had to help his mother to pull up five younger brothers and sisters, and had to drop out of school and leave the country to become an apprentice in Guangzhou Budweiser pharmacy He was the youngest director of Guangzhou in the 1960s, and was appointed deputy director of Guangzhou Mingxing pharmaceutical factory at the age of 23 In 1966, Xu Xiaoxian, 29, responded to the call of the national third line construction, and his family rushed to the mountainous area of Renhua to establish a Limin pharmaceutical factory on a deserted hillside and build a famous third line pharmaceutical factory in Guangdong During the period of national industrial adjustment, he returned to Mingxing pharmaceutical factory as the factory director, responsible for the overall rectification of the enterprise After the cultural revolution, he took the post of deputy director of Guangzhou Institute of pharmaceutical industry, in charge of scientific research In 1985, Xu Xiaoxian, 48, was assigned to Zhuhai to establish Lizhu medicine At that time, Zhuhai did not have the foundation of the pharmaceutical industry, so he was determined to fill in the gap and started the pharmaceutical industry instead of the relatively easy pharmaceutical trade Even if the business of trade was added later, it was for the pharmaceutical industry After that, he put forward the development policy of "an export-oriented enterprise with technology development as the guide, industrial production as the basis and technology, industry and trade as the combination" During his 18 years in office, Lizhu group started its business with 3 million yuan and developed into a large-scale comprehensive high-tech pharmaceutical enterprise with a total asset of more than 2 billion yuan Moreover, it became the first pharmaceutical enterprise listed in both A-share and B-share markets in China After 18 years of service at Lizhu, he chose to leave because the company was acquired Originally, he should have retired, but like a train running at high speed for a long time, Xu Xiaoxian was probably used to the feeling of driving on the road all the time, and he still didn't stop In 2003, with the recommendation of friends, Xu Xiaoxian came to Zhongshan national health industry base and started to establish Zhongshan Anshi to realize the new dream of "selling Chinese drugs to the American market" At that time, Xu Xiaoxian was 66 years old Diqiao calcium preparation, which he chose as his starting product for axis, has become a famous brand in China's calcium preparation market In addition to calcium preparations, axis pharmaceutical's business also includes soft capsules, prescription drugs for export and tablets, injections and other products sold in China 3 Wu Bingxin of Sanzhu: at the age of 76, Wu Bingxin started his first business in 1993 The company was established as Sanzhu, with a registered capital of 300000 yuan In just four years, the sales receipts reached 8 billion yuan, becoming a large private enterprise with a total assets of 4.8 billion yuan Sanzhu has created a market network comparable to the postal network, with more than 600 subsidiaries, more than 2000 offices and more than 13000 workstations in its heyday Its marketing network covers the most remote towns in the mainland of China In March 1998, the Changde middle court of Hunan Province made a first instance decision on the case of "eight bottles of three plants killed an old man by drinking", which made three companies lose the lawsuit, and three plants suddenly fell into the disaster of extinction One year later, in March, Hunan Provincial High Court made a final judgment on the case, and made it clear that "the three oral liquids are safe, non-toxic, effective and reliable high-tech products" At the time of the final adjudication of Changde incident, more than 400 subsidiaries had been closed down, and the "three empires" with annual sales of 8 billion yuan, accumulated profits of 1.8 billion yuan and 150000 employees nearly collapsed After that, Wu Bingxin finished the book on consumption of more than 1.5 million words In 2014, 76 year old Wu Bingxin decided to lead the three trees to rise again In order to go to the battle with light clothes, the three plants have separated other industries with low correlation, such as Jinan Fujiao group, pingyinge Laogong distillery, Beijing Yuquanshan mineral water plant, Jilin Liuhe traditional Chinese medicine factory, etc During the development period of three large-scale enterprises, three large-scale enterprises acquired and controlled more than 30 state-owned enterprises These enterprises span several provinces, and three large-scale enterprises invested a lot of capital, but basically did not form an industrial scale Sanzhu group focuses on the development of core industries, mainly focusing on the pharmaceutical, health care products and cosmetics industries with independent intellectual property rights, focusing on the promotion of probiotic fermentation technology and technology.